» Articles » PMID: 16616831

A Comparison of Cognitive Structure in Schizophrenia Patients and Healthy Controls Using Confirmatory Factor Analysis

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2006 Apr 18
PMID 16616831
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

There is evidence that cognitive task performance breaks down into the same broad domains in schizophrenia as in healthy populations. However, this does not mean that the domains are independent of one another or that the interrelationships among domains are the same between groups. We used confirmatory factor analysis (CFA) to compare the latent structure of a broad neuropsychological battery in schizophrenia patients (n = 148) and healthy controls (n = 157). Main analyses examined the fit of a hierarchical six-factor model, in which associations among the factors were assumed to reflect their strong shared relationship to a general cognitive ability factor. The model incorporated the factors of verbal comprehension, perceptual organization, verbal memory, spatial memory, processing speed, and executive/working memory. The hierarchical model provided a good overall fit to data from both groups. However multiple groups CFA revealed significant differences in factor loadings between groups, reflecting a more generalized latent structure of cognitive ability in schizophrenia. This was also evident in higher bivariate correlations among cognitive domain composite scores calculated from the observed test data. Cognitive ability, as reflected in test performance, appears to be more unitary in schizophrenia than in healthy subjects. This finding may have measurement and treatment implications.

Citing Articles

Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia.

Knizkova K, Kerkova B, Vecerova M, Sustova P, Jonas J, Sironova A Schizophr Res Cogn. 2024; 37:100311.

PMID: 38601889 PMC: 11004639. DOI: 10.1016/j.scog.2024.100311.


Psychosis superspectrum I: Nosology, etiology, and lifespan development.

Jonas K, Cannon T, Docherty A, Dwyer D, Gur R, Gur R Mol Psychiatry. 2024; 29(4):1005-1019.

PMID: 38200290 PMC: 11385553. DOI: 10.1038/s41380-023-02388-2.


European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Vita A, Gaebel W, Mucci A, Sachs G, Erfurth A, Barlati S Eur Psychiatry. 2022; 65(1):e58.

PMID: 36059109 PMC: 9532219. DOI: 10.1192/j.eurpsy.2022.2316.


Lifespan evolution of neurocognitive impairment in schizophrenia - A narrative review.

Fett A, Reichenberg A, Velthorst E Schizophr Res Cogn. 2022; 28:100237.

PMID: 35242606 PMC: 8861413. DOI: 10.1016/j.scog.2022.100237.


Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders.

Eskridge C, Hochberger W, Kaseda E, Lencer R, Reilly J, Keedy S Schizophr Res. 2021; 236:54-60.

PMID: 34392106 PMC: 8464494. DOI: 10.1016/j.schres.2021.07.036.


References
1.
Blanchard J, Neale J . The neuropsychological signature of schizophrenia: generalized or differential deficit?. Am J Psychiatry. 1994; 151(1):40-8. DOI: 10.1176/ajp.151.1.40. View

2.
Nuechterlein K, Barch D, Gold J, Goldberg T, Green M, Heaton R . Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004; 72(1):29-39. DOI: 10.1016/j.schres.2004.09.007. View

3.
Fenton W, Hibbeln J, Knable M . Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry. 2000; 47(1):8-21. DOI: 10.1016/s0006-3223(99)00092-x. View

4.
Tulsky D, Price L . The joint WAIS-III and WMS-III factor structure: development and cross-validation of a six-factor model of cognitive functioning. Psychol Assess. 2003; 15(2):149-62. DOI: 10.1037/1040-3590.15.2.149. View

5.
Deary I . Human intelligence differences: a recent history. Trends Cogn Sci. 2001; 5(3):127-130. DOI: 10.1016/s1364-6613(00)01621-1. View